Doha, Qatar — January 28, 2010 – The Qatar National Cancer Society and SAH Global announced today at Arab Health 2010 that they have signed a Memorandum of Understanding to make the next generation of cancer treatment, Proton Therapy, available to cancer patients in Qatar. The agreement, the first of its kind in the Middle East, promises to promote Proton Therapy as the primary treatment for cancer patients in the State of Qatar. Through this agreement, Qatari citizens and residents will gain access to a cutting edge cancer treatment that provides a higher quality of life and fewer side effects to those suffering from cancer.
The Qatar National Cancer Society (QNCS) in junction with SAH Global, with the signing of this agreement, will become pioneers of this treatment in the region. Through the agreement, SAH Global’s subsidiary SAH Care will coordinate end-to-end treatment through its arrangements with Proton Therapy centers around the world as of second quarter 2010. Consequently, Qatari patients will receive high-quality care and service through all aspects of treatment and travel. Even though waiting time for treatment can exceed 3 months in many cases, Qatari cancer patients will benefit from SAH Care’s network of providers to reduce time-to treatment to a matter of weeks.
“With the signing of the agreement today we have reached a major milestone in the fight against cancer. The QNCS is committed to educating and helping cancer patients in their fight against cancer and this agreement will help us to further our goals and provide a higher quality of life for cancer patients from Qatar,” said Dr. Khalid Bin Jabor Al-Thani, Chairman of the Qatar National Cancer Society.
Feroz Agad, CEO of SAH Global said, “We believe this is the first critical step in creating awareness for this cutting edge and proven technology. We commend Dr. Khalid and the Qatar National Cancer Society for their visionary leadership in working to bring Proton Therapy to the people of Qatar.” SAH Global is in the process of making cutting edge cancer treatments available to the Middle East.
Additionally, SAH Global is committed to bringing next generation cancer treatments to the Middle East and is working with RHT Partners and other advisors to review the opportunity to build an initial flagship Proton Therapy center in the region. SAH Global plans to build a network of Proton Centers in the Middle East in order to better serve the growing number of cancer patients. SAH’s commitment to education will ensure that the Middle East will not only serve as an avenue for treatment, but also as a center for research and development in the fight against cancer.